Client News

Roquefort Therapeutics plc: Investor Presentation
Home / Client News / Roquefort Therapeutics plc: Investor Presentation

Roquefort Therapeutics (LSE:ROQ, OTCQB:ROQAF), the Main Market listed biotech company focused on developing first in class medicines in the high value and high growth oncology market, announces that CEO Ajan Reginald and Executive Chairman Stephen West will give a live presentation via the Investor Meet Company platform at 2pm GMT on Wednesday 1 March 2023. The objective of the presentation will be to provide investors with a Company Update.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.


If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.


Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.

Share This